| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/02/2013 | CA2538075C Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 04/02/2013 | CA2525049C Insoluble globin injectable implant |
| 04/02/2013 | CA2502948C Modified bio-related substance, process for producing the same, and intermediate |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2471145C Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 04/02/2013 | CA2455756C Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 04/02/2013 | CA2453062C Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 04/02/2013 | CA2420652C Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 04/02/2013 | CA2420543C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/28/2013 | WO2013044067A1 Methods for treatment of cervical insufficiency |
| 03/28/2013 | WO2013044044A2 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds |
| 03/28/2013 | WO2013043973A2 Cachexia treatment |
| 03/28/2013 | WO2013043967A1 Romidepsin and 5 - azacitidine for use in treating lymphoma |
| 03/28/2013 | WO2013043864A1 Compositions and methods related to endothelial targeting |
| 03/28/2013 | WO2013043720A1 Regulation of sodium channels by plunc proteins |
| 03/28/2013 | WO2013043669A1 Peptoid compositions for the treatment of alzheimer's disease and polyglutamine expansion disorder |
| 03/28/2013 | WO2013043647A1 Cancer immunotherapy |
| 03/28/2013 | WO2013043591A1 Combination therapy for cancer |
| 03/28/2013 | WO2013043587A1 Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| 03/28/2013 | WO2013043529A1 Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto |
| 03/28/2013 | WO2013043128A1 Sall4 and uses thereof |
| 03/28/2013 | WO2013042943A2 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand |
| 03/28/2013 | WO2013042821A1 Selection of a permissive site for protein redesign, and method for producing a modified protein using same |
| 03/28/2013 | WO2013042684A1 Prophylactic and therapeutic agent for neurological diseases using lipoproteins and prophylactic and therapeutic method for neurological diseases |
| 03/28/2013 | WO2013042156A2 Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease |
| 03/28/2013 | WO2013042093A1 The use of the antibiotic bacitracin in the hydrolytic degradation of rna |
| 03/28/2013 | WO2013041913A1 Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage |
| 03/28/2013 | WO2013041843A1 Cell differentiation |
| 03/28/2013 | WO2013041719A1 Tripeptide kdpt for antiapoptotic treatment |
| 03/28/2013 | WO2013041692A2 Method to predict the presence of inflammation or itaconic acid, irg1 and/or protein irg1 in a subject and pharmaceutical composition for treating or preventing inflammation |
| 03/28/2013 | WO2013041678A1 Novel glucagon analogues |
| 03/28/2013 | WO2013041677A1 Combination therapy using immunoglobulin and c1-inhibitor |
| 03/28/2013 | WO2013041663A2 Modified apidaecin derivatives as antibiotic peptides |
| 03/28/2013 | WO2013041542A1 Pharmaceutical formulations comprising spherolyophilisates of biological molecules |
| 03/28/2013 | WO2013041247A1 Yersinia outer protein m (yopm) in the treatment of psoriasis induced by imiquimod |
| 03/28/2013 | WO2013041246A1 Yersinia outer protein m (yopm) in the treatment of psoriasis |
| 03/28/2013 | WO2013041239A1 Pkm zeta bindin peptides, peptide derivatives and conjugates, and uses thereof |
| 03/28/2013 | WO2013041238A1 Use of kibra peptides, hdac inhibitor or proteasome inhibitor for improving anxiety disorders |
| 03/28/2013 | WO2013040840A1 Methods and agents for preventing, diagnosing, treating or predicting general bacterial infection diseases |
| 03/28/2013 | WO2013040784A1 Lyophilizing insulin liposome powder, oral insulin complex preparation, preparation method therefor, and use thereof |
| 03/28/2013 | WO2013040648A1 Pneumococcal glpo immunogen |
| 03/28/2013 | WO2013006692A3 Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) |
| 03/28/2013 | WO2013006558A3 Compositions and methods for treating skeletal myopathy |
| 03/28/2013 | WO2012177595A9 Compositions and methods for the therapy and diagnosis of cancer |
| 03/28/2013 | WO2012176172A3 Combination therapy with psd-95 inhibitor for ischemia |
| 03/28/2013 | WO2012174117A3 Aromatic-cationic peptides and uses of same |
| 03/28/2013 | WO2012169822A3 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 03/28/2013 | WO2012165916A3 Non-peptidyl polymer-insulin multimer and method for producing the same |
| 03/28/2013 | WO2012165915A3 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate |
| 03/28/2013 | WO2012165900A3 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor |
| 03/28/2013 | WO2012158789A3 Methods and compositions for inhibiting neddylation of proteins |
| 03/28/2013 | WO2012153337A3 Anti-microbial peptides and uses of same |
| 03/28/2013 | WO2012131109A3 Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders |
| 03/28/2013 | WO2011146879A3 Methods and compositions related to modulating autophagy |
| 03/28/2013 | WO2011103920A3 Pharmaceutical or neutraceutical formulation |
| 03/28/2013 | WO2010141918A9 Serum amyloid p derivatives and their preparation and use |
| 03/28/2013 | US20130079387 Antisense oligonucleotide modulation of raf gene expression |
| 03/28/2013 | US20130079344 Ophthalmologic irrigation solutions and method |
| 03/28/2013 | US20130079290 S1p antagonists as adjunct ocular hypotensives |
| 03/28/2013 | US20130079289 Pharmaceutical Compositions |
| 03/28/2013 | US20130079288 Differential effects of drugs on transport in a multi-layer 3d spheroid model |
| 03/28/2013 | US20130079287 Caffeoylalphaneoendorphin peptide derivative and use thereof as anti-itching and anti-atopic agents |
| 03/28/2013 | US20130079286 Muteins of human lipocalin 2 (lcnc,hngal) with affinity for a given target |
| 03/28/2013 | US20130079285 Solubilized collagen fibers and method for producing the same |
| 03/28/2013 | US20130079284 Treatment of t-cell mediated diseases |
| 03/28/2013 | US20130079282 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
| 03/28/2013 | US20130079281 Neuregulin based methods for treating heart failure |
| 03/28/2013 | US20130079279 Pharmaceutical composition comprising ave0010 and insulin glargine |
| 03/28/2013 | US20130079278 Novel Glucagon Analogues |
| 03/28/2013 | US20130079276 Low protein infant formula with increased essential amino acids |
| 03/28/2013 | US20130079275 Reconstituted surfactants having improved properties |
| 03/28/2013 | US20130079274 Pharmaceutical compositions for treating dysregulated inflammatory diseases |
| 03/28/2013 | US20130079273 Cell growth-promoting peptide and use thereof |
| 03/28/2013 | US20130079271 Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 03/28/2013 | US20130078312 Biodegradable Putty Compositions and Implant Devices, Methods, and Kits Relating to the Same |
| 03/28/2013 | US20130078302 Protein C Zymogen and Methods of Use Thereof to Prevent Cancer Metastases |
| 03/28/2013 | US20130078280 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 03/28/2013 | US20130078267 Epitopes Related To Coeliac Disease |
| 03/28/2013 | US20130078266 Immunosuppression By Blocking T Cell Co-Stimulation Signal 2 (B7/CD28 Interaction) |
| 03/28/2013 | US20130078260 Compounds targeting the vegf and/or hif pathway such as sorafenib or vatalanib for use in the treatment of otitis media |
| 03/28/2013 | US20130078257 Use of an active substance binding to cd28 for producing a pharmaceutical composition for the treatment of b-cll |
| 03/28/2013 | US20130078235 Neuregulin based compositions and uses thereof for preventing, treating or delaying the myocardial ischemia-reperfusion injury |
| 03/28/2013 | US20130078231 Dose escalation enzyme replacement therapy for treating acid sphinogmyelinase deficiency |
| 03/28/2013 | US20130078230 Dose escalation enzyme replacement therapy for treating acid sphinogmyelinase deficiency |
| 03/28/2013 | US20130078229 Methods and compositions for the treatment of cancer |
| 03/28/2013 | US20130078227 Embedded chimeric peptide nucleic acids and uses thereof |
| 03/28/2013 | US20130078220 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 03/28/2013 | US20130078218 Hepatitis c therapies |
| 03/28/2013 | US20130078217 2'-chloroacetylenyl substituted nucleoside derivatives |
| 03/28/2013 | US20130078214 Compounds for the Treatment of Hepatitis C |
| 03/28/2013 | CA2849710A1 Cachexia treatment |
| 03/28/2013 | CA2849708A1 Romidepsin and 5 - azacitidine for use in treating lymphoma |
| 03/28/2013 | CA2849673A1 Novel glucagon analogues |
| 03/28/2013 | CA2849267A1 Regulation of sodium channels by plunc proteins |
| 03/28/2013 | CA2849259A1 Cancer immunotherapy |
| 03/28/2013 | CA2849250A1 Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
| 03/28/2013 | CA2848510A1 Combination therapy using immunoglobulin and c1-inhibitor |
| 03/28/2013 | CA2845478A1 Yersinia outer protein m (yopm) in the treatment of psoriasis |
| 03/28/2013 | CA2845183A1 Tripeptide kdpt for antiapoptotic treatment |